SIGN UP
LOG IN
MARKET
IMRN
IMRN
Immuron Ltd
NASDAQ
2.450
+0.040
+1.66%
After Hours: 2.410 -0.04 -1.63% 16:19 04/18 EDT
OPEN
2.450
PREV CLOSE
2.410
HIGH
2.470
LOW
2.420
VOLUME
9.60K
TURNOVER
0
52 WEEK HIGH
5.96
52 WEEK LOW
1.481
MARKET CAP
13.95M
P/E (TTM)
-5.2779
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at IMRN last week (0408-0412)?
Weekly Report · 3d ago
Immuron to host Live Virtual Event
Immuron Limited (ASX: IMC; NASDAQ: IMRN) will be hosting a Live Virtual Event on April 30. The company is an Australian based and globally integrated biopharmaceutical company. The event will be held in Melbourne, Australia.
Barchart · 4d ago
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Ascent Solar Technologies, Inc. (NASDAQ:ASTI) fell sharply during Wednesday's mid-day session. The company announced pricing of a $6 million public offering of shares at $0.14 per share. Marin Software Incorporated shares jumped 152% after the company announced upgrades to its integration with Microsoft Advertising.
Benzinga · 04/10 18:07
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
PriceSmart, Inc. Posted better-than-expected earnings for its second quarter. The company reported quarterly sales of $1.29 billion. PriceSmart shares surged 4.6% to $86.90 in pre-market trading. Marin Software Incorporated shares rose 76.1% after the company announced upgrades to its Microsoft Corp advertising integration.
Benzinga · 04/10 12:12
Immuron gains after Travelan sales update
Immuron gains after Travelan sales update. Australian biotech disclosed latest sales data for its antibacterial medication Travelan. Travelan generated $1.3M globally during the March 2024 quarter. The company has started selling Travelan through Walmart.com for U.S. Customers.
Seeking Alpha · 04/10 11:07
Immuron Announced Travelan Sales Continued Strong Growth
Immuron Limited announces record sales of Travelan®, an over-the-counter immune supplement that targets pathogenic bacteria and toxins in the gastrointestinal tract. Sales commenced on Walmart.com in March 2024. The company is an Australian based and globally integrated biopharmaceutical company.
Benzinga · 04/10 01:01
Weekly Report: what happened at IMRN last week (0401-0405)?
Weekly Report · 04/08 11:59
Weekly Report: what happened at IMRN last week (0325-0329)?
Weekly Report · 04/01 11:56
About IMRN
Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects in Australia, Israel and the United States. The Company's flagship commercial products consist of Travelan and Protectyn. Travelan is an over the counter orally administered passive immunotherapeutic product indicated to reduce the risk of travelers' diarrhea, reduce the risk of minor gastro-intestinal disorders and is antimicrobial. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. The Company has four clinical programs -Travelan (IMM-124E), CampETEC, IMM-529 and Travelan (consumer product).
Webull offers Immuron Ltd stock information, including NASDAQ: IMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading IMRN stock methods without spending real money on the virtual paper trading platform.